Search

Your search keyword '"Coussement, Julien"' showing total 8 results
Start Over Author "Coussement, Julien" Publisher wiley
8 results on '"Coussement, Julien"'

3. Trimethoprim/sulfamethoxazole for nocardiosis in solid organ transplant recipients: Real‐life data from a multicentre retrospective study

Author

Conan, Pierre‐Louis, primary, Matignon, Marie, additional, Bleibtreu, Alexandre, additional, Guillot, Hélène, additional, Van Laecke, Steven, additional, Brenier, Henri, additional, Crochette, Romain, additional, Melica, Giovanna, additional, Fernández‐Ruiz, Mario, additional, Dantal, Jacques, additional, Walti, Laura N., additional, Levi, Charlène, additional, Chauvet, Cécile, additional, De Greef, Julien, additional, Marbus, Sierk D., additional, Mueller, Nicolas J., additional, Ieven, Margareta, additional, Vuotto, Fanny, additional, Lortholary, Olivier, additional, Coussement, Julien, additional, and Lebeaux, David, additional

Published
2021
Full Text
View/download PDF

4. Efficacy of beta-lactam/beta-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)

Author

Pierrotti, Ligia C., Perez-Nadales, Elena, Fernandez-Ruiz, Mario, Gutierrez-Gutierrez, Belen, Hock Tan, Ban, Carratala, Jordi, Oriol, Isabel, Paul, Mical, Cohen-Sinai, Noa, Lopez-Medrano, Francisco, San-Juan, Rafael, Montejo, Miguel, Freire, Maristela P., Cordero, Elisa, David, Miruna D., Merino, Esperanza, Mehta Steinke, Seema, Grossi, Paolo A., Cano, Angela, Seminari, Elena M., Valerio, Maricela, Gunseren, Filiz, Rana, Meenakshi, Mularoni, Alessandra, Martin-Davila, Pilar, van Delden, Christian, Hamiyet Demirkaya, Melike, Kocak Tufan, Zeliha, Loeches, Belen, Iyer, Ranganathan N., Soldani, Fabio, Eriksson, Britt-Marie, Pilmis, Benoit, Rizzi, Marco, Coussement, Julien, Clemente, Wanessa T., Roilides, Emmanuel, Pascual, Alvaro, Martinez-Martinez, Luis, Rodriguez-Bano, Jesus, Torre-Cisneros, Julian, Maria Aguado, Jose, Pierrotti, Ligia C., Perez-Nadales, Elena, Fernandez-Ruiz, Mario, Gutierrez-Gutierrez, Belen, Hock Tan, Ban, Carratala, Jordi, Oriol, Isabel, Paul, Mical, Cohen-Sinai, Noa, Lopez-Medrano, Francisco, San-Juan, Rafael, Montejo, Miguel, Freire, Maristela P., Cordero, Elisa, David, Miruna D., Merino, Esperanza, Mehta Steinke, Seema, Grossi, Paolo A., Cano, Angela, Seminari, Elena M., Valerio, Maricela, Gunseren, Filiz, Rana, Meenakshi, Mularoni, Alessandra, Martin-Davila, Pilar, van Delden, Christian, Hamiyet Demirkaya, Melike, Kocak Tufan, Zeliha, Loeches, Belen, Iyer, Ranganathan N., Soldani, Fabio, Eriksson, Britt-Marie, Pilmis, Benoit, Rizzi, Marco, Coussement, Julien, Clemente, Wanessa T., Roilides, Emmanuel, Pascual, Alvaro, Martinez-Martinez, Luis, Rodriguez-Bano, Jesus, Torre-Cisneros, Julian, and Maria Aguado, Jose

Abstract

Background Whether active therapy with beta-lactam/beta-lactamase inhibitors (BLBLI) is as affective as carbapenems for extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) bloodstream infection (BSI) secondary to urinary tract infection (UTI) in kidney transplant recipients (KTRs) remains unclear. Methods We retrospectively evaluated 306 KTR admitted to 30 centers from January 2014 to October 2016. Therapeutic failure (lack of cure or clinical improvement and/or death from any cause) at days 7 and 30 from ESBL-E BSI onset was the primary and secondary study outcomes, respectively. Results Therapeutic failure at days 7 and 30 occurred in 8.2% (25/306) and 13.4% (41/306) of patients. Hospital-acquired BSI (adjusted OR [aOR]: 4.10; 95% confidence interval [CI]: 1.50-11.20) and Pitt score (aOR: 1.47; 95% CI: 1.21-1.77) were independently associated with therapeutic failure at day 7. Age-adjusted Charlson Index (aOR: 1.25; 95% CI: 1.05-1.48), Pitt score (aOR: 1.72; 95% CI: 1.35-2.17), and lymphocyte count <= 500 cells/mu L at presentation (aOR: 3.16; 95% CI: 1.42-7.06) predicted therapeutic failure at day 30. Carbapenem monotherapy (68.6%, primarily meropenem) was the most frequent active therapy, followed by BLBLI monotherapy (10.8%, mostly piperacillin-tazobactam). Propensity score (PS)-adjusted models revealed no significant impact of the choice of active therapy (carbapenem-containing vs any other regimen, BLBLI- vs carbapenem-based monotherapy) within the first 72 hours on any of the study outcomes. Conclusions Our data suggest that active therapy based on BLBLI may be as effective as carbapenem-containing regimens for ESBL-E BSI secondary to UTI in the specific population of KTR. Potential residual confounding and unpowered sample size cannot be excluded (ClinicalTrials.gov identifier: NCT02852902).

Published
2021
Full Text
View/download PDF

5. Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology

Author

Rammaert, Blandine, Puyade, Mathieu, Cornely, Oliver A., Seidel, Danila, Grossi, Paolo, Husain, Shahid, Picard, Clement, Lass-Floerl, Cornelia, Manuel, Oriol, Le Pavec, Jerome, Lortholary, Olivier, Nagel, Claudia, Westall, Glen, Morrissey, Orla, Chambers, Daniel, Eschertzhuber, Stephan, Coussement, Julien, Vos, Robin, Dupont, Lieven, Dumonceaux, Michel, Campos, Silvia Vidal, Kabbani, Dima, Cervera, Carlos, Blanchard, Elodie, Senechal, Agathe, Brugiere, Olivier, Boussaud, Veronique, Guillemain, Romain, Bervar, Jean-Francois, Claustre, Johanna, Haloun, Alain, Hirschi, Sandrine, Reynaud, Martine, Kneidinger, Nikolaus, Gottlieb, Jens, Roilides, Emmanuel, Zarrinfar, Hossein, Rosso, Lorenzo, Morlacchi, Letizia Corinna, Dell'Amore, Andrea, Loy, Monica, dos Santos, Claudy Oliveira, Monforte, Victor, Teresa Martin-Gomez, Maria, Lopez Medrano, Francisco, Fernandez-Ruiz, Mario, Sole, Amparo, Cifrian, Jose M., Neofytos, Dionysios, Mueller, Nicolas, Benden, Christian, Brill, Anne Kathrin, Kiyan, Esen, Gould, Kate, Gkrania-Klotsas, Effrossyni, David, Miruna, Weigt, Sam, Kwak, Eun Jeong, Silveira, Femanda, Hadjiliadis, Denis, Baddley, John, Danziger-Isakov, Lara, Bhorade, Sangeeta, Ison, Michael, Wolfe, Cameron, Aslam, Saima, Budem, Marie, Musetti, Ana, Rammaert, Blandine, Puyade, Mathieu, Cornely, Oliver A., Seidel, Danila, Grossi, Paolo, Husain, Shahid, Picard, Clement, Lass-Floerl, Cornelia, Manuel, Oriol, Le Pavec, Jerome, Lortholary, Olivier, Nagel, Claudia, Westall, Glen, Morrissey, Orla, Chambers, Daniel, Eschertzhuber, Stephan, Coussement, Julien, Vos, Robin, Dupont, Lieven, Dumonceaux, Michel, Campos, Silvia Vidal, Kabbani, Dima, Cervera, Carlos, Blanchard, Elodie, Senechal, Agathe, Brugiere, Olivier, Boussaud, Veronique, Guillemain, Romain, Bervar, Jean-Francois, Claustre, Johanna, Haloun, Alain, Hirschi, Sandrine, Reynaud, Martine, Kneidinger, Nikolaus, Gottlieb, Jens, Roilides, Emmanuel, Zarrinfar, Hossein, Rosso, Lorenzo, Morlacchi, Letizia Corinna, Dell'Amore, Andrea, Loy, Monica, dos Santos, Claudy Oliveira, Monforte, Victor, Teresa Martin-Gomez, Maria, Lopez Medrano, Francisco, Fernandez-Ruiz, Mario, Sole, Amparo, Cifrian, Jose M., Neofytos, Dionysios, Mueller, Nicolas, Benden, Christian, Brill, Anne Kathrin, Kiyan, Esen, Gould, Kate, Gkrania-Klotsas, Effrossyni, David, Miruna, Weigt, Sam, Kwak, Eun Jeong, Silveira, Femanda, Hadjiliadis, Denis, Baddley, John, Danziger-Isakov, Lara, Bhorade, Sangeeta, Ison, Michael, Wolfe, Cameron, Aslam, Saima, Budem, Marie, and Musetti, Ana

Abstract

Background Scedosporium species and Lomentospora prolificans (S/L) are the second most common causes of invasive mold infections following Aspergillus in lung transplant recipients. Methods We assessed the current practices on management of S/L colonization/infection of the lower respiratory tract before and after lung transplantation in a large number of lung transplant centers through an international practice survey from October 2016 to March 2017. Results A total of 51 respondents from 45 lung transplant centers (17 countries, 4 continents) answered the survey (response rate 58%). S/L colonization was estimated to be detected in candidates by 48% of centers. Only 18% of the centers used a specific medium to detect S/L colonization. Scedosporium spp. colonization was a contraindication to transplantation in 10% of centers whereas L prolificans was a contraindication in 31%; 22% of centers declared having had 1-5 recipients infected with S/L in the past 5 years. Conclusions This survey gives an overview of the current practices regarding S/L colonization and infection in lung transplant centers worldwide and underscores the need of S/L culture procedure standardization before implementing prospective studies.

Published
2019

6. Immunosuppression reduction in liver and kidney transplant recipients with suspected bacterial infection: A multinational survey

Author

Shepshelovich, Daniel, primary, Tau, Noam, additional, Green, Hefziba, additional, Rozen‐Zvi, Benaya, additional, Issaschar, Assaf, additional, Falcone, Marco, additional, Coussement, Julien, additional, Zusman, Oren, additional, Manuel, Oriol, additional, Mor, Eytan, additional, Torre‐Cisneros, Julian, additional, and Yahav, Dafna, additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results